Ebola Vaccine Trials Begin in Switzerland
Ebola vaccine trials begin in Switzerland – Ebola vaccine trials began in Lausanne, Switzerland on Tuesday after receiving the green light from the country’s authorities.
Swiss regulators announced they would allow trials of an experimental vaccine made by Britain’s GlaxoSmithKine, and tests on some 120 individuals were set to get under way at the CHUV hospital in Lausanne Friday, the hospital said.
“We have never before received so many volunteers so quickly,” Blaise Genton, who heads CHUV’s infectuous disease division, told reporters.
“The trial will test the safety of the vaccine and its capacity to induce an immune response,” WHO said.
It added that results of the trials in Switzerland and elsewhere will “provide the basis for planning subsequent trials involving several thousand participants, and for choosing vaccine dose-level for efficacy trials.”
Category: News Videos, Videos
